Clinical significance of baseline Pan-Immune-Inflammation Value and its dynamics in metastatic colorectal cancer patients under first-line chemotherapy

Pan-Immune-Inflammation Value (PIV) has been recently proposed as a new blood-based prognostic biomarker in metastatic colorectal cancer (mCRC). Herein we aimed to validate its prognostic significance and to evaluate its utility for disease monitoring in patients with mCRC receiving first-line chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Martelo, Martín, González-García, Alejandro, Vidal-Ínsua, Yolanda, Blanco-Freire, Cristina, Brozos-Vázquez, Elena María, Abdulkader-Nallib, Ihab, Álvarez-Fernández, Javier, Lázare-Iglesias, Héctor, García-Martínez, Carolina, Betancor, Yoel Z., Sánchez-Ares, María, Tubío, Jose M. C., Vázquez-Rivera, Francisca, Candamio-Folgar, Sonia, López-López, Rafael, Ruiz-Bañobre, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046216/
https://www.ncbi.nlm.nih.gov/pubmed/35477740
http://dx.doi.org/10.1038/s41598-022-10884-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046216/
https://www.ncbi.nlm.nih.gov/pubmed/35477740
http://dx.doi.org/10.1038/s41598-022-10884-8

Ejemplares similares